Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTAFR | P25105 | 17/20 | 0.70 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.63 |
| ▸ | GABRA5 | P31644 | 3/20 | 0.63 |
| ▸ | GABRA2 | P47869 | 3/20 | 0.63 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.63 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9379183 | 0.86 | PTAFR (0.71) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9382741 | 0.82 | PTAFR (1.00) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9382164 | 0.82 | PTAFR (0.70) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9383726 | 0.82 | PTAFR (0.88) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL16063031 | 0.81 | GABRA1 (0.79) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9379596 | 0.80 | PTAFR (0.72) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9385465 | 0.80 | PTAFR (0.75) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9377911 | 0.80 | PTAFR (0.71) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9379331 | 0.79 | GABRA1 (0.74) | PTAFRGABRA1GABRA5GABRA2GABRB2 | |
| SCHEMBL9379665 | 0.79 | PTAFR (0.78) | PTAFRGABRA1GABRA5GABRA2GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0320992-B1 | Triazolodiazepine derivatives | HOFFMANN LA ROCHE (CH) | 1994-07-27 | — | — | EP | disclosed |
| US-4959361-A | Triazolo(4,3-A)(1,4)benzodiazepines and thieno (3,2-F)(1,2,4)triazolo(4,3-A)(1,4)diazepine compounds which have useful activity as platelet activating factor (PAF) antagonists | HOFFMANN-LA ROCHE INC. (US) | 1990-09-25 | — | — | US | disclosed |
| EP-0320992-A2 | Triazolodiazepine derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1989-06-21 | — | — | EP | disclosed |